Sponsor or institution
Clinical trials and research at Reelin Therapeutics, INC.
As of November 12, 2026, Find a Trial lists 2 NIH-funded research projects at this institution, with $479,862 in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2NIH research projects
NIH-funded research (2)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
Next-generation gamma-secretase modulators for Alzheimer's disease
A company is developing new drugs that may reduce an Alzheimer-related protein in older adults who are at risk for or living with Alzheimer’s disease.
-
Investigating how variations in a protein affect Alzheimer's disease and Down syndrome.
This study is looking at how a protein called Reelin affects brain health in people with Alzheimer's and Down syndrome, and it will test whether certain antibodies can help reduce inflammation and improve brain function in a mouse model of Down syndrome, with the hope of finding new treatments for patients.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.